Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

An evaluation of the Australian Rotavirus Surveillance Program.

Roberts-Witteveen AR, Patel MS, Roche PW.

Commun Dis Intell Q Rep. 2008 Sep;32(3):326-32.

2.

Rotavirus surveillance in Australia.

Ward KA, McIntyre PB, Kirkwood CD, Roche PW, Ferson MJ, Van Buynder PG, Roberts-Witteveen AR, Kesson AM, Krause VL, McAnulty JM.

Commun Dis Intell Q Rep. 2008 Mar;32(1):82-7. No abstract available.

3.

Invasive pneumococcal disease in Australia, 2006.

Roche PW, Krause V, Cook H, Barralet J, Coleman D, Sweeny A, Fielding J, Giele C, Gilmour R, Holland R, Kampen R; Enhanced Invasive Pneumococcal Disease Surveillance Working Group, Brown M, Gilbert L, Hogg G, Murphy D; Pneumococcal Working Party of the Communicable Diseases Network Australia.

Commun Dis Intell Q Rep. 2008 Mar;32(1):18-30.

4.

Tuberculosis notifications in Australia, 2006.

Roche PW, Krause V, Konstantinos A, Bastian I, Antic R, Brown L, Christensen A, Gebbie S, Hurwitz M, Misrachi A, Justin W; National Tubeculosis Advisory Committee; Communicable Disease Network Australia.

Commun Dis Intell Q Rep. 2008 Mar;32(1):1-11.

5.

Australia's notifiable diseases status, 2005: annual report of the National Notifiable Diseases Surveillance System.

Owen R, Roche PW, Hope K, Yohannes K, Roberts A, Liu C, Stirzaker S, Kong F, Bartlett M, Donovan B, East I, Fitzsimmons G, McDonald A, McIntyre PB, Menzies RI.

Commun Dis Intell Q Rep. 2007 Mar;31(1):1-70. Erratum in: Commun Dis Intell. 2007;31(2):262.

6.

Annual report of the National Influenza Surveillance Scheme, 2005.

Firestone SM, Barr IG, Roche PW, Walker JC.

Commun Dis Intell Q Rep. 2006;30(2):189-200.

7.

Australia's notifiable diseases status, 2004, annual report of the National Notifiable Diseases Surveillance System.

Yohannes K, Roche PW, Roberts A, Liu C, Firestone SM, Bartlett M, East I, Hull BP, Kirk MD, Lawrence GL, McDonald A, McIntyre PB, Menzies RI, Quinn HE, Vadjic C.

Commun Dis Intell Q Rep. 2006;30(1):1-79.

8.

Tuberculosis notifications in Australia, 2004.

Roche PW, Antic R, Bastian I, Brown L, Christensen A, Hurwitz M, Konstantinos A, Krause VL, McKinnon M, Misrachi A, Waring J; National Tuberculosis Advisory Committee; Communicable Diseases Network Australia.

Commun Dis Intell Q Rep. 2006;30(1):93-101.

9.

Invasive pneumococcal disease in Australia, 2004.

Roche PW, Krause VL, Bartlett M, Coleman D, Cook H, Davis C, Fielding JE, Holland R, Giele C, Gilmour R, Kampen R, Brown M, Gilbert L, Hogg G, Murphy D; Pneumococcal Working Party of the Communicable Diseases Network Australia.

Commun Dis Intell Q Rep. 2006;30(1):80-92.

10.

Evaluation of the Australian Gonococcal Surveillance Programme.

Samaan G, Roche PW, Greig JE, Tapsall JW; Australian Gonococcal Surveillance Programme.

Commun Dis Intell Q Rep. 2005;29(2):143-9.

11.

Annual report of the National Influenza Surveillance Scheme, 2004.

Li J, Hampson A, Roche PW, Yohannes K, Spencer JD.

Commun Dis Intell Q Rep. 2005;29(2):125-36.

12.

The paper grip test for screening on intrinsic muscle paralysis in the foot of leprosy patients.

de Win MM, Theuvenet WJ, Roche PW, de Bie RA, van Mameren H.

Int J Lepr Other Mycobact Dis. 2002 Mar;70(1):16-24.

PMID:
12120036
14.

A method for rapid detection of rifampicin-resistant isolates of Mycobacterium leprae.

Honoré N, Roche PW, Grosset JH, Cole ST.

Lepr Rev. 2001 Dec;72(4):441-8.

PMID:
11826480
15.

Vaccination with DNA of the Mycobacterium tuberculosis 85B antigen protects mouse foot pad against infection with M. leprae.

Roche PW, Neupane KD, Failbus SS, Kamath A, Britton WJ.

Int J Lepr Other Mycobact Dis. 2001 Jun;69(2):93-8.

PMID:
11757171
16.

Prediction of 'highly skin smear positive' cases among MB leprosy patients using clinical parameters.

Lemaster JW, Shwe T, Butlin CR, Roche PW.

Lepr Rev. 2001 Mar;72(1):23-8.

PMID:
11355514
17.

'Jhum-jhum'--a common paraesthesia in leprosy.

Lemaster JW, John O, Roche PW.

Lepr Rev. 2001 Mar;72(1):100-1. No abstract available.

PMID:
11355511
18.

Dapsone drug resistance in the MDT era.

Roche PW, Neupane KD, Failbus SS, Butlin CR.

Int J Lepr Other Mycobact Dis. 2000 Sep;68(3):323-5. No abstract available.

PMID:
11221097
19.

Rapid detection of resistance to rifampicin in Mycobacterium leprae.

Roche PW, Shrestha N, Thomas A, Honore N, Cole ST.

Lepr Rev. 2000 Dec;71 Suppl:S96-7; discussion S97-9. No abstract available.

PMID:
11201897
20.

Immunoprophylaxis against Mycobacterium leprae infection with subunit vaccines.

Britton WJ, Martin E, Kamath AT, Neupane KD, Roche PW.

Lepr Rev. 2000 Dec;71 Suppl:S176-81.

PMID:
11201878
21.

DNA encoding a single mycobacterial antigen protects against leprosy infection.

Martin E, Roche PW, Triccas JA, Britton WJ.

Vaccine. 2001 Jan 8;19(11-12):1391-6.

PMID:
11163661
22.

Interferon-gamma responses to candidate leprosy skin-test reagents detect exposure to leprosy in an endemic population.

Manandhar R, LeMaster JW, Butlin CR, Brennan PJ, Roche PW.

Int J Lepr Other Mycobact Dis. 2000 Mar;68(1):40-8.

PMID:
10834068
23.
24.

Risk factors for erythema nodosum leprosum.

Manandhar R, LeMaster JW, Roche PW.

Int J Lepr Other Mycobact Dis. 1999 Sep;67(3):270-8.

PMID:
10575406
25.

Contribution of type 1 reactions to sensory and motor function loss in borderline leprosy patients and the efficacy of treatment with prednisone.

Roche PW, Theuvenet WJ, Le Master JW, Butlin CR.

Int J Lepr Other Mycobact Dis. 1998 Sep;66(3):340-7.

PMID:
9934360
27.

Molecular and immunological analyses of the Mycobacterium avium homolog of the immunodominant Mycobacterium leprae 35-kilodalton protein.

Triccas JA, Winter N, Roche PW, Gilpin A, Kendrick KE, Britton WJ.

Infect Immun. 1998 Jun;66(6):2684-90.

28.

IgM anti-phenolic glycolipid-I antibody measurements from skin-smear sites: correlation with venous antibody levels and the bacterial index.

Butlin CR, Soares D, Neupane KD, Failbus SS, Roche PW.

Int J Lepr Other Mycobact Dis. 1997 Dec;65(4):465-8.

PMID:
9465156
29.

Risk factors for type 1 reactions in leprosy.

Roche PW, Le Master J, Butlin CR.

Int J Lepr Other Mycobact Dis. 1997 Dec;65(4):450-5.

PMID:
9465153
30.

A 35-kilodalton protein is a major target of the human immune response to Mycobacterium leprae.

Triccas JA, Roche PW, Winter N, Feng CG, Butlin CR, Britton WJ.

Infect Immun. 1996 Dec;64(12):5171-7.

31.

Human T-cell epitopes on the Mycobacterium tuberculosis secreted protein MPT64.

Roche PW, Feng CG, Britton WJ.

Scand J Immunol. 1996 Jun;43(6):662-70.

PMID:
8658056
32.
33.

BCG vaccination against tuberculosis: past disappointments and future hopes.

Roche PW, Triccas JA, Winter N.

Trends Microbiol. 1995 Oct;3(10):397-401. Review.

PMID:
8564359
34.

T-cell determinants and antibody binding sites on the major mycobacterial secretory protein MPB59 of Mycobacterium bovis.

Roche PW, Peake PW, Billman-Jacobe H, Doran T, Britton WJ.

Infect Immun. 1994 Dec;62(12):5319-26.

35.

Differential T cell responses to mycobacteria-secreted proteins distinguish vaccination with bacille Calmette-Guérin from infection with Mycobacterium tuberculosis.

Roche PW, Triccas JA, Avery DT, Fifis T, Billman-Jacobe H, Britton WJ.

J Infect Dis. 1994 Nov;170(5):1326-30.

PMID:
7963739
36.

Mechanisms of persistence of mycobacteria.

Britton WJ, Roche PW, Winter N.

Trends Microbiol. 1994 Aug;2(8):284-8. Review.

PMID:
7981971
37.

Identification of a Mycobacterium leprae-specific T cell epitope on the 70 kDa heat shock protein.

Roche PW, Peake PW, Davenport MP, Britton WJ.

Immunol Cell Biol. 1994 Jun;72(3):215-21.

PMID:
7522215
38.

Sequence and expression of the Mycobacterium leprae dnaJ gene.

Harvey SS, McKenzie KR, Roche PW, Britton WJ.

J Gen Microbiol. 1993 Sep;139(9):2003-8.

PMID:
8245828
39.

Serological monitoring of the response to chemotherapy in leprosy patients.

Roche PW, Britton WJ, Failbus SS, Neupane KD, Theuvenet WJ.

Int J Lepr Other Mycobact Dis. 1993 Mar;61(1):35-43.

PMID:
8326179
40.

Analysis of B-cell epitopes in the variable C-terminal region of the Mycobacterium leprae 70-kilodalton heat shock protein.

Peake PW, Britton WJ, Davenport MP, Roche PW, McKenzie KR.

Infect Immun. 1993 Jan;61(1):135-41.

41.
42.

Antibody responses to the 18-kDa protein of Mycobacterium leprae in leprosy and tuberculosis patients.

Roche PW, Prestidge RL, Watson JD, Britton WJ.

Int J Lepr Other Mycobact Dis. 1992 Jun;60(2):201-7.

PMID:
1381739
43.

Cellular immune responses to mycobacterial heat shock proteins in Nepali leprosy patients and controls.

Roche PW, Theuvenet WJ, Britton WJ.

Int J Lepr Other Mycobact Dis. 1992 Mar;60(1):36-43.

PMID:
1602192
44.

Risk factors for type-1 reactions in borderline leprosy patients.

Roche PW, Theuvenet WJ, Britton WJ.

Lancet. 1991 Sep 14;338(8768):654-7.

PMID:
1679473
45.

The response to chemotherapy of serum Mycobacterium leprae-specific antigen in multibacillary leprosy patients.

Roche PW, Britton WJ, Neupane KD, Failbus SS, Cho SN, Theuvenet WJ.

Am J Trop Med Hyg. 1991 Jun;44(6):702-8.

PMID:
1858971
46.

The systemic influence of recombinant interleukin 2 on the manifestations of lepromatous leprosy.

Kaplan G, Britton WJ, Hancock GE, Theuvenet WJ, Smith KA, Job CK, Roche PW, Molloy A, Burkhardt R, Barker J, et al.

J Exp Med. 1991 Apr 1;173(4):993-1006.

47.

Serological responses in primary neuritic leprosy.

Roche PW, Britton WJ, Failbus SS, Theuvenet WJ, Lavender M, Adiga RB.

Trans R Soc Trop Med Hyg. 1991 Mar-Apr;85(2):299-302.

PMID:
1887493
48.

Operational value of serological measurements in multibacillary leprosy patients: clinical and bacteriological correlates of antibody responses.

Roche PW, Britton WJ, Failbus SS, Williams D, Pradhan HM, Theuvenet WJ.

Int J Lepr Other Mycobact Dis. 1990 Sep;58(3):480-90.

PMID:
2205683
49.

Heterogeneity of serological responses in paucibacillary leprosy--differential responses to protein and carbohydrate antigens and correlation with clinical parameters.

Roche PW, Britton WJ, Failbus SS, Ludwig H, Theuvenet WJ, Adiga RB.

Int J Lepr Other Mycobact Dis. 1990 Jun;58(2):319-27.

PMID:
1695912
50.

Self-administered drug compliance in Nepali leprosy patients.

Roche PW, Failbus S, Britton W.

Trop Doct. 1989 Apr;19(2):59-61.

PMID:
2734837

Supplemental Content

Loading ...
Support Center